IPP Bureau
Enveric Biosciences advances drug development for mental health indications
By IPP Bureau - July 16, 2022
Advancing to IND-enabling studies with multiple drug candidates
Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
By IPP Bureau - July 15, 2022
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Syngene signs 10-year biologics manufacturing agreement with Zoetis
By IPP Bureau - July 15, 2022
Syngene's collaboration with Zoetis started in 2011
Healthcare Triangle closes $6.5 million private placement
By IPP Bureau - July 15, 2022
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Cipla Health signs agreement to acquire Endura Mass
By IPP Bureau - July 15, 2022
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
By IPP Bureau - July 15, 2022
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax statement on EMA Nuvaxovid label update related to allergic reaction
By IPP Bureau - July 15, 2022
Novavax’ clinical development program reported no severe allergic reactions
U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine
By IPP Bureau - July 15, 2022
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Philips highlights AI-powered precision diagnosis portfolio at ECR 2022
By IPP Bureau - July 15, 2022
Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes
USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list
By IPP Bureau - July 14, 2022
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Shilpa Medicare’s Unit VI, Bengaluru facility has been issued UK MHRA GMP
By IPP Bureau - July 14, 2022
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
By IPP Bureau - July 14, 2022
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Bajaj Healthcare forays into the highly regulated - Opiate Processing Business for the GOI
By IPP Bureau - July 14, 2022
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
W.R. Grace to expand capacity at small-molecule API plant
By IPP Bureau - July 13, 2022
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Heathcare startup MedTel to raise around USD 10mn in Series A
By IPP Bureau - July 13, 2022
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
